Omnicell OMCL 深 沪
等待开盘 12-18 09:30:00 美东时间
45.79
+1.050
+2.35%
华盛通- 最 高46.37
- 今 开44.75
- 成交量 88.57万股
- 最 低 44.02
- 昨 收 44.74
- 总市值 21.03亿
- 52周最高 47.69
- 市盈率 静 169.03
- 换手率 1.93%
- 52周最低 22.66
- 委 比 92.39%
- 总股本 4593.43万
- 历史最高 187.285
- 量 比 1.50
- 振 幅 5.25%
- 历史最低 12.33
- 每 手 1
- 风险率 5.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
Benchmark Maintains Buy on Omnicell, Raises Price Target to $50
Benchmark analyst Bill Sutherland maintains Omnicell (NASDAQ:OMCL) with a Buy and raises the price target from $45 to $50.
12-09 21:12
Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
Evoke Pharma reported a 61% year-over-year increase in third-quarter 2025 net product sales to $4.3 million. The company has entered into an agreement to be acquired by QOL Medical for $11.00 per share in cash. Additionally, the patent for Gimoti, its nasal spray for diabetic gastroparesis, has been extended to November 2038. Despite higher expenses, the company remains focused on growth and expanded distribution. The tender offer for the acquisi...
11-13 12:00
Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal
Evoke Pharma surges after QOL Medical announces $11 cash acquisition, a 140% premium, expected to close by the end of 2025.
11-04 23:20
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
Benchmark Maintains Buy on Omnicell, Raises Price Target to $45
Benchmark analyst Bill Sutherland maintains Omnicell (NASDAQ:OMCL) with a Buy and raises the price target from $40 to $45.
10-31 22:22
Omnicell shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 guidance above estimates.
Omnicell shares are trading higher after the company reported better-than-expec...
10-30 21:00
Earnings Scheduled For October 30, 2025
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
亿纬锂能三季度营收创新高，动力及储能电池出货量快速增长
10月23日晚间，亿纬锂能（300014.SZ）披露2025年第三季度财报。数据显示，公司单季实现营业收入168.32亿元，同比增长35.85%，环比增长9....
10-24 19:10
亿纬锂能：第三季度营收续创新高 归母利润环比增长140.16%
10月23日晚间，全球动力电池与储能领域头部企业亿纬锂能（证券代码：300014.SZ）披露2025年第三季度报告。财务数据显示，公司第三季度经营业绩持续增长，营业总收入达168.32亿元，同比增长35.85%，创下单季营收历史新高；归母净利润12.11亿元，同比增长15.13%，环比增长140.16%。
10-23 22:57
